- UK firm Phytopharm and Unilever to develop a slimming aid from Hoodia cactus.
- Production of Hoodia at Phytopharm's nursery to rise from 8 million to potentially hundreds of millions.
- Phytopharm will receive an initial fee of £6.5m from Unilever, out of a potential £21m, plus royalties.
- Unilever will help Phytopharm develop snacks containing Hoodia extract.
- Phytopharm initially hoped to market a slimming drug with Pfizer.
